Millions of Americans to see reduced medication costs in 2025
- AARP: 3.2 million Americans estimated to save on prescriptions in 2025
- Lower costs come from out-of-pocket cap included in Inflation Reduction Act
- Drugmakers: Law will cause higher costs, more denials and fewer treatments
ovp test
Male shot by female at Shreveport apartment
Class to create biodiverse backyard
Rules for outbursts at Caddo School Board Meeting
(NewsNation) — The cost of prescription drugs in America is a major issue, especially on the campaign trail, and a new report suggests a significant impact on millions of older Americans nationwide.
A new AARP report reveals that by 2025, more than 3 million Americans will save over $1,000 on their prescriptions due to the Biden administration’s Inflation Reduction Act.
With inflation running high and Americans spending heavily on medications each year, this could be a deciding factor for voters.
How much will Americans save?
According to AARP, Medicare recipients will see cuts in their prescription drug costs starting next year. Beginning in January, a new $2,000 out-of-pocket cap instituted in the the 2022 Inflation Reduction Act will take effect as a part of the first-ever deal with drug manufacturers to lower prices on 10 commonly used drugs for Medicare benefits.
This cap, linked to the Part D prescription drug program that covers around 56 million people, is expected to lower drug costs for 3.2 million Americans.
Diana Divito, a cancer patient from Pennsylvania, was paying more than $800 per month for her leukemia medication.
“I almost had a heart attack when I saw the first copay,” she recalled. “What do people do who can’t afford this? Sadly, many of them probably don’t survive.”
The biggest relief will be felt by people like Divito who rely on high-priced branded drugs.
According to the White House, this change could save Americans hundreds, if not thousands, of dollars on a case-by-case basis, while collectively saving taxpayers billions of dollars on medication costs.
Older Americans worry about drug costs
The cost of prescription drugs is a top concern for many senior voters.
A study published last month in the Journal of the American Medical Association found more than half of older Americans were “very concerned” about the costs of medical care.
Drugmakers argue law will hurt consumers
Drug manufactures aren’t pleased with these changes.
The Pharmaceutical Research and Manufacturers of America has criticized the Inflation Reduction Act, calling it a bad deal being forced on American patients. The group argues it will lead to higher costs, more insurance denials and fewer available treatments and cures for patients.
